Resmed RMD
NYSE RMD
$224.99 -3.51 (-1.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

Resmed (RMD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)

Analysis

Resmed (RMD) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 10.68%
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 25.17%
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 9.67%
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 8.70%
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 17.65%
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 3.48%
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 13.54%
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 2.65%
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn 5.08%
10 Steris 20.01 Bn 19.54 Bn 684.20 Mn 7.96%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.65%
Mar 31, 2026 2.35%
Dec 31, 2025 2.58%
Sep 30, 2025 4.96%
Jun 30, 2025 3.40%
Mar 31, 2025 1.41%
Dec 31, 2024 2.87%
Sep 30, 2024 6.23%
Jun 30, 2024 5.74%
Mar 31, 2024 5.85%
Dec 31, 2023 6.29%
Sep 30, 2023 7.92%
Jun 30, 2023 5.09%
Mar 31, 2023 10.01%
Dec 31, 2022 8.58%
Sep 30, 2022 8.37%
Jun 30, 2022 6.08%
Mar 31, 2022 10.30%
Dec 31, 2021 7.79%
Sep 30, 2021 6.97%